CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Cash flows from operating activities:
Net cash provided by operating activities	$ 949,075	$ 927,809
Cash flows from investing activities:
Capital expenditures	(114,022)	(162,726)
Origination of finance receivables	(2,927,372)	(3,009,479)
Collections on finance receivables	2,480,122	2,440,466
Proceeds from finance receivables sold	0	312,571
Sales and redemptions of marketable securities	6,916	40,014
Other	356	251
Net cash used by investing activities	(554,000)	(378,903)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	893,668	1,193,396
Repayments of medium-term notes	(400,000)	(451,336)
Repayments of securitization debt	(367,298)	(535,616)
Borrowings of asset-backed commercial paper	371,253	33,428
Repayments from Issuance of Asset-Backed Commercial Paper	129,690	55,170
Net decrease in credit facilities and unsecured commercial paper	(225,038)	(146,328)
Net change in restricted cash	3,767	30,981
Dividends paid	(190,121)	(190,387)
Purchase of common stock for treasury	(465,167)	(374,234)
Excess tax benefits from share-based payments	0	1,291
Issuance of common stock under employee stock option plans	7,884	6,444
Net cash used by financing activities	(500,742)	(487,531)
Effect of exchange rate changes on cash and cash equivalents	28,817	6,700
Net increase (decrease) in cash and cash equivalents	(76,850)	68,075
Cash and cash equivalents:
Cash and cash equivalents—beginning of period	759,984	722,209
Net increase in cash and cash equivalents	(76,850)	68,075
Cash and cash equivalents—end of period	$ 683,134	$ 790,284